Pradeep Harish
Liverpool, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Beyond data and technology: the need for new thinking to enable the era of precision prevention.
Journal: BMC medicine
Published: March 09, 2026
Innate Immunocompetent hiPSC-Derived Neurospheroids Capture Early CNS Responses to rAAV.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 15, 2025
Polyfunctional T cells and unique cytokine clusters imprint the anti rAAV2/rAAV9 vector immune response.
Journal: Frontiers in immunology
Published: June 17, 2024
Novel Metabolomic Approach for Identifying Pathology-Specific Biomarkers in Rare Diseases: A Case Study in Oculopharyngeal Muscular Dystrophy (OPMD).
Journal: Metabolites
Published: May 04, 2023
Systemic Delivery of a Monoclonal Antibody to Immunologically Block Myostatin in the A17 Mouse Model of OPMD.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 18, 2022
Knockdown of Muscle-Specific Ribosomal Protein L3-Like Enhances Muscle Function in Healthy and Dystrophic Mice.
Journal: Nucleic acid therapeutics
Published: June 03, 2021
Age-Associated Salivary MicroRNA Biomarkers for Oculopharyngeal Muscular Dystrophy.
Journal: International journal of molecular sciences
Published: July 12, 2020
Inhibition of Myostatin Reduces Collagen Deposition in a Mouse Model of Oculopharyngeal Muscular Dystrophy (OPMD) With Established Disease.
Journal: Frontiers in physiology
Published: December 19, 2019
Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy.
Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy.
Journal: Human molecular genetics
Published: November 05, 2018
A pilot study to elucidate effects of artificial selection by size on the zebrafish (Danio rerio) fast skeletal muscle transcriptome.
Journal: Comparative biochemistry and physiology. Part A, Molecular & integrative physiology
Published: October 31, 2018
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD).
Journal: Journal of cachexia, sarcopenia and muscle
Published: September 06, 2018
Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophy.
Journal: Human gene therapy
Published: April 11, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026